HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Single injection recombinant vesicular stomatitis virus vaccines protect ferrets against lethal Nipah virus disease.

AbstractBACKGROUND:
Nipah virus (NiV) is a highly pathogenic zoonotic agent in the family Paramyxoviridae that is maintained in nature by bats. Outbreaks have occurred in Malaysia, Singapore, India, and Bangladesh and have been associated with 40 to 75% case fatality rates. There are currently no vaccines or postexposure treatments licensed for combating human NiV infection.
METHODS AND RESULTS:
Four groups of ferrets received a single vaccination with different recombinant vesicular stomatitis virus vectors expressing: Group 1, control with no glycoprotein; Group 2, the NiV fusion protein (F); Group 3, the NiV attachment protein (G); and Group 4, a combination of the NiV F and G proteins. Animals were challenged intranasally with NiV 28 days after vaccination. Control ferrets in Group 1 showed characteristic clinical signs of NiV disease including respiratory distress, neurological disorders, viral load in blood and tissues, and gross lesions and antigen in target tissues; all animals in this group succumbed to infection by day 8. Importantly, all specifically vaccinated ferrets in Groups 2-4 showed no evidence of clinical illness and survived challenged. All animals in these groups developed anti-NiV F and/or G IgG and neutralizing antibody titers. While NiV RNA was detected in blood at day 6 post challenge in animals from Groups 2-4, the levels were orders of magnitude lower than animals from control Group 1.
CONCLUSIONS:
These data show protective efficacy against NiV in a relevant model of human infection. Further development of this technology has the potential to yield effective single injection vaccines for NiV infection.
AuthorsChad E Mire, Krista M Versteeg, Robert W Cross, Krystle N Agans, Karla A Fenton, Michael A Whitt, Thomas W Geisbert
JournalVirology journal (Virol J) Vol. 10 Pg. 353 (Dec 13 2013) ISSN: 1743-422X [Electronic] England
PMID24330654 (Publication Type: Journal Article)
Chemical References
  • Antibodies, Neutralizing
  • Antibodies, Viral
  • Drug Carriers
  • Immunoglobulin G
  • Vaccines, Synthetic
  • Viral Proteins
  • Viral Vaccines
Topics
  • Animals
  • Antibodies, Neutralizing (blood)
  • Antibodies, Viral (blood)
  • Disease Models, Animal
  • Drug Carriers
  • Female
  • Ferrets
  • Genetic Vectors
  • Henipavirus Infections (prevention & control)
  • Immunoglobulin G (blood)
  • Nipah Virus (genetics, immunology)
  • Survival Analysis
  • Vaccination (methods)
  • Vaccines, Synthetic (administration & dosage, genetics, immunology)
  • Vesiculovirus (genetics)
  • Viral Proteins (genetics, immunology)
  • Viral Vaccines (administration & dosage, genetics, immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: